Studying cholesterol's role in memory and thinking decline
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how cholesterol and related substances in the body may be linked to the development and progression of certain dementias. It aims to find better ways to understand and track these diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 85 years old
- You have a diagnosis of Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, or corticobasal degeneration based on current medical criteria
- Your score on a common dementia test (MMSE) is above 10
- You do not have other major brain or mental health conditions
- You do not have severe long-term metabolic diseases (like severe diabetes or thyroid disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and imaging markers (biomarkers) to better understand and diagnose dementia and mild cognitive impairment. It aims to improve early detection and may help guide future treatments.
This study tests whether actively lowering blood pressure and cholesterol can slow down or prevent memory decline in people who carry a genetic risk for Alzheimer's disease. It aims to see if these treatments can help keep your brain healthy as you age.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
This study looks for ways to lower the risk of developing dementia and improve thinking skills in people over 60. You may be eligible if you do not have dementia but have early warning signs of memory or thinking changes.
This study looks at what factors might increase the risk of memory and thinking problems in people with coronary heart disease. It includes testing your memory and metabolism during a hospital stay.
This study tests two approaches together: a computer-based brain training program and a stronger cholesterol-lowering medicine, to see if they can help improve memory and thinking in people with narrowed brain arteries. You would be randomly assigned to different combinations of the two, and the doctors will monitor your progress.
Hear when a new Dementias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.